BlackRock’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$51.2M Buy
2,845,567
+244,558
+9% +$4.9M ﹤0.01% 2486
2025
Q4
$60.9M Buy
2,601,009
+19,723
+0.8% +$428K ﹤0.01% 2396
2025
Q3
$51.5M Buy
2,581,286
+176,045
+7% +$3.16M ﹤0.01% 2474
2025
Q2
$33M Sell
2,405,241
-18,222
-0.8% -$175K ﹤0.01% 2723
2025
Q1
$26.8M Sell
2,423,463
-43,748
-2% -$466K ﹤0.01% 2762
2024
Q4
$26.3M Sell
2,467,211
-30,732
-1% -$368K ﹤0.01% 2868
2024
Q3
$31.7M Buy
2,497,943
+303,993
+14% +$4.51M ﹤0.01% 2751
2024
Q2
$36.8M Buy
2,193,950
+477,137
+28% +$6.79M ﹤0.01% 2593
2024
Q1
$25.8M Sell
1,716,813
-2,491
-0.1% -$40.7K ﹤0.01% 2840
2023
Q4
$25.8M Buy
1,719,304
+521,657
+44% +$6.77M ﹤0.01% 2863
2023
Q3
$16.8M Buy
1,197,647
+99,731
+9% +$1.6M ﹤0.01% 3042
2023
Q2
$11.4M Buy
1,097,916
+813,377
+286% +$8.97M ﹤0.01% 3361
2023
Q1
$2.63M Sell
284,539
-64,731
-19% -$596K ﹤0.01% 3924
2022
Q4
$3.1M Buy
349,270
+4,492
+1% +$42.5K ﹤0.01% 3941
2022
Q3
$2.87M Buy
344,778
+4,366
+1% +$36.1K ﹤0.01% 4009
2022
Q2
$2.79M Sell
340,412
-1,360,364
-80% -$9.34M ﹤0.01% 4091
2022
Q1
$14.8M Sell
1,700,776
-27,318
-2% -$213K ﹤0.01% 3363
2021
Q4
$16.4M Buy
1,728,094
+15,871
+0.9% +$224K ﹤0.01% 3391
2021
Q3
$28.8M Sell
1,712,223
-14,816
-0.9% -$235K ﹤0.01% 3044
2021
Q2
$26.4M Buy
1,727,039
+56,434
+3% +$1.02M ﹤0.01% 3129
2021
Q1
$32.5M Buy
1,670,605
+141,114
+9% +$3M ﹤0.01% 2898
2020
Q4
$27.6M Buy
1,529,491
+43,890
+3% +$920K ﹤0.01% 2835
2020
Q3
$28.7M Buy
1,485,601
+19,796
+1% +$448K ﹤0.01% 2655
2020
Q2
$38.3M Buy
1,465,805
+68,829
+5% +$1.68M ﹤0.01% 2405
2020
Q1
$24.9M Buy
1,396,976
+24,113
+2% +$651K ﹤0.01% 2487
2019
Q4
$45.8M Sell
1,372,863
-22,067
-2% -$602K ﹤0.01% 2419
2019
Q3
$33.2M Buy
1,394,930
+56,377
+4% +$1.84M ﹤0.01% 2530
2019
Q2
$48.1M Buy
1,338,553
+915,970
+217% +$33.8M ﹤0.01% 2337
2019
Q1
$15.6M Buy
422,583
+122,554
+41% +$5.14M ﹤0.01% 2874
2018
Q4
$12.9M Buy
300,029
+197,410
+192% +$8.88M ﹤0.01% 2953
2018
Q3
$4.85M Buy
102,619
+12,829
+14% +$596K ﹤0.01% 3514
2018
Q2
$4.47M Buy
+89,790
New +$5.23M ﹤0.01% 3532

Other funds holding URGN